Skip to main content

Table 2 Colonoscopic findings of the enrolled patients

From: Evaluation of the diagnostic performance of estimated fecal calprotectin and serum intelectin-1 and C-reactive protein solo or in combination for differentiation between patients with query ulcerative colitis and irritable bowel syndrome

Data

Number (%)

Distribution of ulcers through the colorectal tract

Rectum

46 (61.3%)

Sigmoid colon

17 (22.7%)

Left colon

8 (10.7%)

Right colon

4 (5.3%)

Total

75 (100%)

Site of ulcerations among UC patients

Colorectal

24 (47.1%)

Rectum

22 (43.1%)

Colon

5 (9.8%)

Mayo endoscopic score (MES)

UC

MES-1

7 (13.7%)

MES-2

34 (66.7%)

MES-3

10 (19.6%)

IBS

MES-0

219 (75.3%)

MES-1

72 (24.7%)